公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2011 | Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001 | Kuo, SH; Hsu, CH; Chen, LT; Lu, YS; Lin, CH; Yeh, PY; Jeng, HJ; Gao, M; Yeh, KH; Cheng, AL | EUROPEAN JOURNAL OF CANCER | 0 | 0 | |
2008 | Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: need for a revisit of surgical treatment. | Kuo, SH; Chen, LT; Wu, MS; Lin, CW; Yeh, KH; Kuo, KT; Yeh, PY; Tzeng, YS; Wang, HP; Hsu, PN; Lin, JT; Cheng, AL. | Ann Surg | | | |
2020 | On Privacy Aware Carriers for Value-Possessed e-Invoices Considering Intelligence Mining | Cha, SC; Wang, H; Tan, ZY; YUH-JZER JOUNG ; Tseng, YC; Yeh, KH | IEEE TRANSACTIONS ON EMERGING TOPICS IN COMPUTATIONAL INTELLIGENCE | 2 | 2 | |
2006 | A pathway for TNFalpha -induced Bcl10 nuclear translocation: Bcl10 is upregulated by NFkappa B, phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus. | Yeh, PY; Kuo, SH; Yeh, KH; Chuang, SE; Hsu, CH; Chang, WC; Lin, HI; Gao, M; Cheng, AL. | J Biol Chem | | | |
2005 | Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer. | Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL. | Oncology | | | |
2005 | Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer. | Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL. | Oncology | | | |
2005 | Phase II study of weekly vinorelbine and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer. | Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Cheng, AL. | Br J Cancer | | | |
2005 | Phase II study of weekly vinorelbine and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer. | Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Cheng, AL. | Br J Cancer | | | |